Gibson, Dunn & Crutcher advised Alcon Inc. on the deal, and Morrison & Foerster advised OcuMension Therapeutics. OcuMension Therapeutics (“OcuMension”), a Hong Kong-listed, China-based ophthalmic pharmaceutical...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP advised XCOM Labs, and Taft, Stettinius & Hollister advised Globalstar on the deal. Globalstar, Inc. (NYSE: GSAT) announced that Paul E. Jacobs,...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP is advising Mirum Pharmaceuticals, Cooley LLP is advising Travere Therapeutics, Inc. in the transaction. Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) and Travere...
You must be a Standard 1 Year member to access this content.
Cooley and Wilson Sonsini Goodrich & Rosati advised Vividion Therapeutics on the deal. Vividion Therapeutics, a biopharmaceutical company utilizing novel discovery technologies to unlock high-value, traditionally...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis represented XPDI, while Cooley represented Core Scientific in the transaction. Power & Digital Infrastructure Acquisition Corp. (Nasdaq: XPDI), a publicly traded special purpose...
You must be a Standard 1 Year member to access this content.
Cooley advised Clarabridge on the deal, while Shearman & Sterling represented Qualtrics International. Clarabridge, a customer experience management platform focused on omnichannel text and speech analytics,...
You must be a Standard 1 Year member to access this content.
